Inflammatory bowel diseases (IBD) include Crohn's disease (CD) and Ulcerative Colitis (UC), heterogeneous diseases characterized by a misfunction of the immune system and a chronic inflammation of bowel, often invalidating and requiring life-long treatment. It is crucial to early diagnose these conditions and to promptly start an appropriate treatment that aims at resolving symptoms and preventing/delaying complications. Diagnosis relies on endoscopic methods, but also imaging by computed tomography (CT) and magnetic resonance imaging (MRI). Nuclear medicine techniques are not first line diagnostic tools despite they are very sensitive modalities for the evaluation of the state of activity of the disease. To this purpose, specific radiopharmaceuticals have been developed as probes to detect specific molecular antigens, to obtain information on the activity of the disease but also on the nature of the process to tailor treatment and for follow-up. Among the many radiopharmaceuticals available, we will concentrate in particular, on the use of radiolabeled white blood cell scintigraphy.

Gamma camera imaging of inflammatory bowel diseases / Signore, Alberto; Lauri, Chiara; Micheli, Federica; Baccini, Flavia. - (2022), pp. 494-502. [10.1016/B978-0-12-822960-6.00164-2].

Gamma camera imaging of inflammatory bowel diseases

Signore, Alberto;Lauri, Chiara;Micheli, Federica;Baccini, Flavia
2022

Abstract

Inflammatory bowel diseases (IBD) include Crohn's disease (CD) and Ulcerative Colitis (UC), heterogeneous diseases characterized by a misfunction of the immune system and a chronic inflammation of bowel, often invalidating and requiring life-long treatment. It is crucial to early diagnose these conditions and to promptly start an appropriate treatment that aims at resolving symptoms and preventing/delaying complications. Diagnosis relies on endoscopic methods, but also imaging by computed tomography (CT) and magnetic resonance imaging (MRI). Nuclear medicine techniques are not first line diagnostic tools despite they are very sensitive modalities for the evaluation of the state of activity of the disease. To this purpose, specific radiopharmaceuticals have been developed as probes to detect specific molecular antigens, to obtain information on the activity of the disease but also on the nature of the process to tailor treatment and for follow-up. Among the many radiopharmaceuticals available, we will concentrate in particular, on the use of radiolabeled white blood cell scintigraphy.
2022
Nuclear medicine and molecular imaging
9780128229804
9780128229606
crohn's disease; imaging; inflammatory bowel disease; radiolabeled white blood cell; radiopharmaceuticals; spec; ulcerative colitis
02 Pubblicazione su volume::02a Capitolo o Articolo
Gamma camera imaging of inflammatory bowel diseases / Signore, Alberto; Lauri, Chiara; Micheli, Federica; Baccini, Flavia. - (2022), pp. 494-502. [10.1016/B978-0-12-822960-6.00164-2].
File allegati a questo prodotto
File Dimensione Formato  
Signore_Gamma-camera-imaging-of inflammatory-bowel-diseases_2022.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.82 MB
Formato Adobe PDF
1.82 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1670735
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact